Angiogen, Inc.

Address

Angiogen, Inc.
4050 Sorrento Valley Blvd, Ste O
San Diego, CA, 92121 0142

Information

DUNS:
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Histone Deacetylase Inhibitors for Cancer Treatment

    Amount: $135,887.00

    DESCRIPTION (provided by applicant): Histone deacetylases (HDACs) comprise a family of enzymes that catalyze the removal of acetyl groups from lysine residues of histones. They mediate chromatin remod ...

    STTRPhase I2005Department of Health and Human Services
  2. EFFECTS OF ANGIOGENESIS FACTORS ON SKIN FLAP SURVIVAL

    Amount: $50,000.00

    IN SPITE OF THE COMMON USE OF SKIN GRAFTS AND SKIN FLAPS IN PLASTIC AND RECONSTRUCTIVE SURGERY, SERIOUS COMPLICATIONS STILL ARISE. THE COMPLETE OR PARTIAL NECROSIS THAT CAN OCCUR IN SURGICAL FLAPS OR ...

    SBIRPhase I1989Department of Health and Human Services
  3. RETINOPATHY TREATMENT: HEPARIN-TARGETED ANTIANGIOGENESIS

    Amount: $50,000.00

    PROLIFERATIVE RETINOPATHY, OR OCULAR DISORDERS CHARACTERIZED BY ABNORMAL RETINAL NEOVASCULARIZATION, PRESENTS A SERIOUS CHALLENGE IN OPHTHALMOLOGY. CONVENTIONALTREATMENTS-LASER PHOTOCOAGULATION AND VI ...

    SBIRPhase I1987Department of Health and Human Services
  4. VASCULARIZATION OF MANY SOLID TUMORS OCCURS IN VIVO AS A CONSEQUENCE OF THE VECTORIAL GROWTH OF HOST CAPILLARY ENDOTHELIAL CELLS ALONG A CONCENTRATION GRADIENT OF TUMOR- PRODUCED, DIFFUSIBLE ANGIOGENESIS FACTOR(S).

    Amount: $50,000.00

    VASCULARIZATION OF MANY SOLID TUMORS OCCURS IN VIVO AS A CONSEQUENCE OF THE VECTORIAL GROWTH OF HOST CAPILLARY ENDOTHELIAL CELLS ALONG A CONCENTRATION GRADIENT OF TUMOR- PRODUCED, DIFFUSIBLE ANGIOGENE ...

    SBIRPhase I1986Department of Health and Human Services
  5. THE PROPOSED STUDY TARGETS THE WELL-VASCULARIZED AND REFRACTORY CLASS OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS FOR THE DEVELOPMENT OF NOVEL METHODS FOR DETECTING THE PRESENCE AND QUANTITATING AMOUNTS OF SPECIFIC TUMOR-PRODUCED ANGIO- GENESIS FACTORS (AF).

    Amount: $50,000.00

    THE PROPOSED STUDY TARGETS THE WELL-VASCULARIZED AND REFRACTORY CLASS OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS FOR THE DEVELOPMENT OF NOVEL METHODS FOR DETECTING THE PRESENCE AND QUANTITATING AMOUNTS OF ...

    SBIRPhase I1986Department of Health and Human Services
  6. Histone Deacetylase Inhibitors for Cancer Treatment

    Amount: $135,887.00

    DESCRIPTION (provided by applicant): Histone deacetylases (HDACs) comprise a family of enzymes that catalyze the removal of acetyl groups from lysine residues of histones. They mediate chromatin remod ...

    SBIRPhase IDepartment of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government